ATA129-EBV-301: Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease after Failure of Ritux

Project: Research project

Project Details

StatusActive
Effective start/end date6/30/18 → 8/31/50

Funding

  • Atara Biotherapeutics